Preetha Anand

Department of Developmental and Cell Biology, University of California, Irvine

Affiliated withUniversity of California, Irvine

Research Area

Biography

Preetha Anand has not added Biography.
If you are Preetha Anand and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 5	2012

Other Publications

Article	Year
Interfacial properties as predictors of radioresistance in cervical cancer. Journal of colloid and interface science\| PubMed ID: 17610888	2007
Bioavailability of curcumin: problems and promises. Molecular pharmaceutics\| PubMed ID: 17999464	2007
Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer letters\| PubMed ID: 18462866	2008
Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer letters\| PubMed ID: 18479807	2008
Potential of spice-derived phytochemicals for cancer prevention. Planta medica\| PubMed ID: 18612945	2008
Cancer is a preventable disease that requires major lifestyle changes. Pharmaceutical research\| PubMed ID: 18626751	2008
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochemical pharmacology\| PubMed ID: 18775680	2008
Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-kappa B pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppre... Molecular cancer therapeutics\| PubMed ID: 18852134	2008
Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leu... Blood\| PubMed ID: 18952893	2009
Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis. Cancer research\| PubMed ID: 18974130	2008
Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. Molecular cancer therapeutics\| PubMed ID: 19372569	2009
Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. International journal of cancer. Journal international du cancer\| PubMed ID: 19623659	2009
Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochemical pharmacology\| PubMed ID: 19735646	2010
Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. International journal of cancer. Journal international du cancer\| PubMed ID: 19908231	2010
Characterization and mechanistic studies of a novel melanoma-targeting construct containing IÎºBa for specific inhibition of nuclear factor-ÎºB activity. Neoplasia (New York, N.Y.)\| PubMed ID: 20927315	2010
Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acc... Biochemical pharmacology\| PubMed ID: 21924245	2011
Mechanical stochastic tug-of-war models cannot explain bidirectional lipid-droplet transport. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 22084076	2011
Casein kinase 2 reverses tail-independent inactivation of kinesin-1. Nature communications\| PubMed ID: 22453827	2012